Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Inhibitory Effect of Flavonoid Xanthomicrol on Triple-Negative Breast Tumor Via Regulation of Cancer-Associated Micrornas Publisher Pubmed



Attari F1 ; Keighobadi F2 ; Abdollahi M3 ; Arefian E4 ; Lotfizadeh R1 ; Sepehri H1 ; Moridi Farimani M5
Authors

Source: Phytotherapy Research Published:2021


Abstract

Breast cancer is the leading cause of cancer death in women worldwide. Due to the side effects of current chemo-reagents on healthy tissues, it is essential to search for alternative compounds with less toxicity and better efficacy. In the present study, we have investigated the anticancer effects of flavonoid xanthomicrol on the mice breast cancer model using MTT assay, cell cycle and Annexin/PI analysis, colony formation assay, H&E staining, immunohistochemistry, and miRNA analysis. Our results demonstrated that xanthomicrol decreased the cell viability and clonogenic capability, induced G1-arrest and apoptosis in the breast cancer cells in vitro, and caused a significant reduction in the volume and weight of mice tumors in vivo. In addition, xanthomicrol reduced the expression of TNFα, VEGF, MMP9, and Ki67, while upregulating the expression of apoptotic markers such as Bax, caspase3, and caspase9. Finally, the expression of miR21, miR27, and miR125, known as oncomirs, decreased significantly after xanthomicrol administration, while the expression of miR29 and miR34, functioning as tumor suppressors, increased significantly (p <.001). Our data demonstrated that xanthomicrol can induce apoptosis and suppress angiogenesis in breast cancer cells due to its inhibitory effect on oncomirs and its stimulatory effect on tumor suppressor miRNAs. © 2020 John Wiley & Sons Ltd
Other Related Docs
16. Targeting Epigenetics in Cancer: Therapeutic Potential of Flavonoids, Critical Reviews in Food Science and Nutrition (2021)
17. Anti-Neoplastic Effects of Aprotinin on Human Breast Cancer Cell Lines: In Vitro Study, Advances in Clinical and Experimental Medicine (2019)